Swiss Vaccine Research Institute
  • ABOUT
    • Our Mission
    • Our people
    • Founder Institutions
  • RESEARCH
  • TECHNOLOGICAL PLATFORMS
    • EPFL – Protein Plateform
    • CHUV – Fluidim Platform
    • IRB – Antibodies Discovery
    • UZH – Humanized Mice Platform
  • EDUCATION
  • PARTNERSHIP
    • Support Swiss vaccine research Institute
  • INFO CENTRE
    • Scientific Publications
    • Contact
Select Page

Fenwick, C., Turelli, P., Pellaton, C., Farina, A., Campos, J., Raclot, C., Pojer, F., Cagno, V., Nussle, S. G., D’Acremont, V., Fehr, J., Puhan, M., Pantaleo, G., and Trono, D.

Aug 4, 2021 | Publications

A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma

Levy, Y., Wiedemann, A., Hejblum, B. P., Durand, M., Lefebvre, C., Surenaud, M., Lacabaratz, C., Perreau, M., Foucat, E., Dechenaud, M., Tisserand, P., Blengio, F., Hivert, B., Gauthier, M., Cervantes-Gonzalez, M., Bachelet, D., Laouenan, C., Bouadma, L., Timsit, J. F., Yazdanpanah, Y., Pantaleo, G., Hocini, H., Thiebaut, R., and French, C. c. s. g.

Jul 23, 2021 | Publications

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death

Meylan S, Dafni U, Lamoth F, Tsourti Z, Lobritz MA, Regina J, Bressin P, Senn L, Grandbastien B, Andre C., Fenwick C., D’Acremont V., Croxatto A., Guilleret I., Greub G., Manuel O., Calandra T., Pantaleo G., Lazor-Blanchet C.; COVID-19 MISS group

Jul 5, 2021 | Publications

SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study

Deng, Y., Chatterjee, B., Zens, K., Zdimerova, H., Muller, A., Schuhmachers, P., Ligeon, L. A., Bongiovanni, A., Capaul, R., Zbinden, A., Holler, A., Stauss, H., Hammerschmidt, W., and Munz, C.

Jun 10, 2021 | Publications

CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion

Filippidis, P., van Ouwenaller, F., Cerutti, A., Geiger-Jacquod, A., Sempoux, C., Pantaleo, G., Moradpour, D., and Lamoth, F.

May 18, 2021 | Publications

Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis
« Older Entries
Next Entries »

Archives

  • March 2023 (1)
  • November 2022 (1)
  • September 2022 (1)
  • August 2022 (3)
  • May 2022 (1)
  • April 2022 (2)
  • December 2021 (1)
  • November 2021 (1)
  • October 2021 (1)
  • September 2021 (2)
  • August 2021 (2)
  • July 2021 (2)
  • June 2021 (1)
  • May 2021 (5)
  • April 2021 (5)
  • March 2021 (1)
  • January 2021 (3)
  • November 2020 (2)
  • June 2020 (1)
  • May 2020 (1)
  • February 2020 (1)
  • January 2020 (1)
  • December 2019 (1)
  • November 2019 (3)
  • September 2019 (1)
  • August 2019 (1)
  • July 2019 (2)
  • May 2019 (2)
  • April 2019 (1)
  • February 2019 (1)
  • October 2018 (1)
  • August 2018 (3)
  • January 2018 (1)
  • September 2017 (1)
  • August 2017 (1)
  • July 2017 (1)
  • May 2017 (3)
  • August 2016 (19)
  • September 2015 (1)
  • August 2015 (11)
  • December 2014 (2)
  • November 2014 (2)
  • October 2014 (2)
  • September 2014 (8)
  • August 2014 (2)
  • June 2014 (1)
  • May 2014 (1)
  • April 2014 (2)
  • September 2013 (16)
  • September 2012 (13)
  • September 2011 (12)
  • September 2010 (6)
  • September 2009 (2)
  • September 2008 (1)
Copyright © Swiss Vaccine Research Institute 2017